S&P 500   2,996.95 (+0.03%)
DOW   26,837.86 (+0.19%)
QQQ   191.70 (-0.08%)
AAPL   242.43 (+1.03%)
MSFT   136.51 (+0.10%)
GOOGL   1,250.98 (+0.79%)
AMZN   1,753.04 (-0.72%)
CGC   21.12 (-0.14%)
NVDA   193.87 (-0.89%)
BABA   170.25 (+0.21%)
GE   9.04 (-0.22%)
TSLA   253.06 (-0.99%)
AMD   31.20 (-0.98%)
T   38.02 (-0.39%)
F   9.02 (-0.55%)
ACB   3.56 (-0.56%)
PRI   125.75 (-0.04%)
NFLX   271.78 (+1.91%)
BAC   31.25 (+0.16%)
GILD   65.98 (+0.18%)
S&P 500   2,996.95 (+0.03%)
DOW   26,837.86 (+0.19%)
QQQ   191.70 (-0.08%)
AAPL   242.43 (+1.03%)
MSFT   136.51 (+0.10%)
GOOGL   1,250.98 (+0.79%)
AMZN   1,753.04 (-0.72%)
CGC   21.12 (-0.14%)
NVDA   193.87 (-0.89%)
BABA   170.25 (+0.21%)
GE   9.04 (-0.22%)
TSLA   253.06 (-0.99%)
AMD   31.20 (-0.98%)
T   38.02 (-0.39%)
F   9.02 (-0.55%)
ACB   3.56 (-0.56%)
PRI   125.75 (-0.04%)
NFLX   271.78 (+1.91%)
BAC   31.25 (+0.16%)
GILD   65.98 (+0.18%)
Log in

Valeritas Stock Price, News & Analysis (NASDAQ:VLRX)

$1.32
+0.01 (+0.76 %)
(As of 10/23/2019 09:42 AM ET)
Today's Range
$1.32
Now: $1.32
$1.32
50-Day Range
$1.22
MA: $1.52
$1.94
52-Week Range
$1.10
Now: $1.32
$25.40
Volume633 shs
Average Volume170,780 shs
Market Capitalization$7.01 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VLRX
CUSIPN/A
Phone908-927-9920

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$26.40 million
Book Value$2.86 per share

Profitability

Net Income$-45,930,000.00
Net Margins-187.83%
Return on Equity-45,700.07%

Miscellaneous

Employees125
Market Cap$7.01 million
Next Earnings Date11/8/2019 (Estimated)
OptionableNot Optionable

Receive VLRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VLRX and its competitors with MarketBeat's FREE daily newsletter.


Valeritas (NASDAQ:VLRX) Frequently Asked Questions

What is Valeritas' stock symbol?

Valeritas trades on the NASDAQ under the ticker symbol "VLRX."

How were Valeritas' earnings last quarter?

Valeritas Holdings Inc (NASDAQ:VLRX) announced its earnings results on Thursday, August, 8th. The company reported ($2.73) earnings per share for the quarter, topping the Zacks' consensus estimate of ($2.90) by $0.17. The firm earned $7.51 million during the quarter, compared to analyst estimates of $7.50 million. Valeritas had a negative net margin of 187.83% and a negative return on equity of 45,700.07%. View Valeritas' Earnings History.

When is Valeritas' next earnings date?

Valeritas is scheduled to release their next quarterly earnings announcement on Friday, November 8th 2019. View Earnings Estimates for Valeritas.

What guidance has Valeritas issued on next quarter's earnings?

Valeritas updated its FY 2019 earnings guidance on Wednesday, October, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $31-33 million, compared to the consensus revenue estimate of $32.05 million.

What price target have analysts set for VLRX?

2 Wall Street analysts have issued 1 year price objectives for Valeritas' stock. Their predictions range from $12.00 to $14.00. On average, they anticipate Valeritas' stock price to reach $13.00 in the next year. This suggests a possible upside of 884.8% from the stock's current price. View Analyst Price Targets for Valeritas.

What is the consensus analysts' recommendation for Valeritas?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Valeritas in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Valeritas.

Has Valeritas been receiving favorable news coverage?

News coverage about VLRX stock has been trending negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Valeritas earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 9.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Valeritas.

Who are some of Valeritas' key competitors?

What other stocks do shareholders of Valeritas own?

Who are Valeritas' key executives?

Valeritas' management team includes the folowing people:
  • Mr. John E. Timberlake, Pres, CEO & Director (Age 54)
  • Mr. Erick J. Lucera CPA, CFA, CFO & Sec. (Age 51)
  • Mr. Geoffrey H. Jenkins, Exec. VP of Manufacturing, Operations and R&D (Age 67)
  • Dr. Matthew H. Nguyen, Chief Commercial Officer (Age 49)
  • Mr. Scott A. Huie, VP of Regulatory Affairs/Quality Assurance and Compliance

When did Valeritas IPO?

(VLRX) raised $60 million in an IPO on Thursday, March 23rd 2017. The company issued 6,000,000 shares at a price of $9.00-$11.00 per share. Cowen and Company and Wedbush PacGrow served as the underwriters for the IPO and Roth Capital Partners and B. Riley & Co. were co-managers.

How do I buy shares of Valeritas?

Shares of VLRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Valeritas' stock price today?

One share of VLRX stock can currently be purchased for approximately $1.32.

How big of a company is Valeritas?

Valeritas has a market capitalization of $7.01 million and generates $26.40 million in revenue each year. The company earns $-45,930,000.00 in net income (profit) each year or ($34.20) on an earnings per share basis. Valeritas employs 125 workers across the globe.View Additional Information About Valeritas.

What is Valeritas' official website?

The official website for Valeritas is http://www.valeritas.com/.

How can I contact Valeritas?

Valeritas' mailing address is 750 ROUTE 202 SOUTH SUITE 600, BRIDGEWATER NJ, 08807. The company can be reached via phone at 908-927-9920 or via email at [email protected]


MarketBeat Community Rating for Valeritas (NASDAQ VLRX)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  224 (Vote Outperform)
Underperform Votes:  124 (Vote Underperform)
Total Votes:  348
MarketBeat's community ratings are surveys of what our community members think about Valeritas and other stocks. Vote "Outperform" if you believe VLRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VLRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel